Nukkleus (NASDAQ:DFNS) Shares Up 0.4% – What’s Next?

Nukkleus Inc. (NASDAQ:DFNS)’s stock price shot up 0.4% on Wednesday . The company traded as high as $0.2823 and last traded at $0.2751. 1,622,538 shares were traded during mid-day trading, a decline of 67% from the average session volume of 4,876,915 shares. The stock had previously closed at $0.2740.

Wall Street Analysts Forecast Growth

Several equities research analysts recently weighed in on DFNS shares. Weiss Ratings restated a “sell (d+)” rating on shares of Nukkleus in a report on Monday, March 23rd. Wall Street Zen lowered Nukkleus from a “hold” rating to a “sell” rating in a report on Saturday, April 18th. One analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the stock has a consensus rating of “Sell”.

Nukkleus Price Performance

The company has a current ratio of 0.25, a quick ratio of 0.21 and a debt-to-equity ratio of 0.07. The stock’s 50-day simple moving average is $0.47 and its two-hundred day simple moving average is $2.22.

Nukkleus (NASDAQ:DFNS) last released its earnings results on Wednesday, May 20th. The company reported ($1.14) earnings per share for the quarter. The business had revenue of $3.65 million for the quarter.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the company. GM Advisory Group LLC acquired a new stake in Nukkleus during the fourth quarter worth about $56,000. BNP Paribas Financial Markets acquired a new stake in Nukkleus during the second quarter worth about $56,000. Price T Rowe Associates Inc. MD acquired a new stake in Nukkleus during the fourth quarter worth about $57,000. Millennium Management LLC acquired a new stake in Nukkleus during the fourth quarter worth about $60,000. Finally, State Street Corp increased its stake in Nukkleus by 70.7% in the fourth quarter. State Street Corp now owns 17,863 shares of the company’s stock valued at $72,000 after acquiring an additional 7,400 shares during the period. Institutional investors and hedge funds own 12.47% of the company’s stock.

About Nukkleus

Nukkleus Inc, a financial technology company, provides blockchain-enabled technology solutions worldwide. It focuses on providing software and technology solutions for retail foreign exchange trading industry. The company provides transactions platform for dealing and risk management services. It also offers cross-border payment and transactions solutions and blockchain-enabled financial services solutions to institutional investors. In addition, the company provides software, technology, customer sales and marketing, and risk management technology hardware and software solutions.